HCA_ZYMEWORKS ZWI-ZW25-101 187-17

ZWI-ZW25-101 (anti-Phase 1 trial of ZW25 in patients with locally advanced (unresectable) and/or metastatic HER2-expressing cancers

Phase 1 trial of ZW25 in patients with locally advanced (unresectable) and/or metastatic HER2-expressing cancers
Phase I
All Other|Cancer
Multiple Tumor Types
Diana Hanna, M.D.
Zymeworks Inc.
Chi Nguyen
  • Hoag Research
  • xSJH Southern California